The Efficacy of Flupentixol-Melitracen in the Adjuvant Therapy of Ulcerative Colitis in the Chinese Population: A Meta-Analysis

Table 1

Characteristics of studies included in the meta-analysis.

Study	Year of publication	Sample size	Sample size		Medicine		Study design	Age, years ( or min-max)	Male
			Treated group	Control group	Treated group	Control group
Li et al. 2006 [23]	2006	60	32	28	Mesalazine 1 g po qid; flupentixol-melitracen 10.5 mg po bid	Mesalazine; 1 g po qid	RCT	26-64	39
Hu 2011 [22]	2011	46	23	23	Mesalazine 1 g po qid; flupentixol-melitracen 10.5 mg po bid	Mesalazine; 1 g po qid	RCT	21-65	30
Fan 2011 [19]	2011	52	26	26	Mesalazine 1 g po qid; flupentixol-melitracen 10.5 mg po bid	Mesalazine; 1 g po qid	RCT	NA	NA
Yang 2013 [24]	2013	40	20	20	Mesalazine 1 g po qid; flupentixol-melitracen 10.5 mg po bid	Mesalazine; 1 g po qid	RCT	21-60	23
Hu 2013 [21]	2013	60	30	30	Mesalazine 1 g po qid; flupentixol-melitracen 10.5 mg po bid	Mesalazine; 1 g po qid	RCT	24-52	NA
Duan 2014 [18]	2014	60	30	30	Mesalazine 1 g po qid; flupentixol-melitracen 10.5 mg po bid	Mesalazine; 1 g po qid	RCT	22-59	16
Huang 2014 [9]	2014	40	20	20	Mesalazine 1 g po qid; flupentixol-melitracen 10.5 mg po bid	Mesalazine; 1 g po qid	RCT	21-60	23
Xie et al. 2014 [11]	2014	80	40	40	Mesalazine 1 g po tid; flupentixol-melitracen 10.5 mg po bid	Mesalazine; 1 g po tid	RCT		32
Li 2014 [10]	2014	60	30	30	Mesalazine 1 g po qid; flupentixol-melitracen 10.5 mg po bid	Mesalazine; 1 g po qid	RCT	23-75	35
Feng 2014 [20]	2014	78	38	40	Mesalazine 1 g po qid; flupentixol-melitracen 10.5 mg po bid	Mesalazine; 1 g po qid	RCT	22-64	48
Lin 2015 [12]	2015	78	39	39	Mesalazine 0.2-0.3 mg/kg enema bid; flupentixol-melitracen 10.5 mg po bid	Mesalazine; 0.2-0.3 mg/kg enema bid	RCT	26-69	42